NGFR and central nervous system cancer: To directly test the role of p75NTR processing in glioma invasion, we constructed cleavage-resistant chimeric proteins of p75NTR by replacing either the transmembrane (p75FasTM) or the extracellular stalk domain of p75NTR (p75FasS) with equivalent domains from the Fas receptor [39] (Figure 3C).